Biomeme Acquisitions
Biomeme has acquired 1 company and its latest acquisition was Predigen on Aug 2021
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Predigen
Aug 2021
Source »undisclosed
Predigen is a North Carolina-based biotechnology company that researches and develops mRNA host response therapeutics for the treatment of infectious and autoimmune diseases.